AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,692,000 | +86.7% | 605,625 | +52.0% | 0.00% | 0.0% |
| Q2 2020 | $3,049,000 | +444.5% | 398,559 | +338.6% | 0.00% | – |
| Q1 2020 | $560,000 | -92.2% | 90,864 | -84.6% | 0.00% | -100.0% |
| Q4 2019 | $7,176,000 | +222.4% | 589,634 | +205.9% | 0.00% | +100.0% |
| Q3 2019 | $2,226,000 | -41.6% | 192,747 | -49.5% | 0.00% | 0.0% |
| Q2 2019 | $3,812,000 | +1095.0% | 381,567 | +1442.2% | 0.00% | – |
| Q1 2019 | $319,000 | -66.8% | 24,741 | -60.8% | 0.00% | – |
| Q4 2018 | $960,000 | -53.1% | 63,172 | -38.3% | 0.00% | -100.0% |
| Q3 2018 | $2,047,000 | +1.4% | 102,365 | -1.1% | 0.00% | 0.0% |
| Q2 2018 | $2,019,000 | -11.1% | 103,513 | -8.2% | 0.00% | 0.0% |
| Q1 2018 | $2,272,000 | +32.6% | 112,746 | -12.8% | 0.00% | – |
| Q4 2017 | $1,713,000 | -83.8% | 129,304 | -77.4% | 0.00% | -100.0% |
| Q3 2017 | $10,574,000 | -21.2% | 573,106 | -21.4% | 0.00% | -25.0% |
| Q2 2017 | $13,415,000 | -70.5% | 729,013 | -63.9% | 0.00% | -42.9% |
| Q1 2017 | $45,502,000 | -35.5% | 2,017,750 | -0.4% | 0.01% | -41.7% |
| Q4 2016 | $70,498,000 | +179.9% | 2,025,826 | +97.1% | 0.01% | +33.3% |
| Q3 2016 | $25,188,000 | +7.9% | 1,027,673 | +5.3% | 0.01% | +12.5% |
| Q2 2016 | $23,336,000 | +158.4% | 975,575 | +152.7% | 0.01% | +166.7% |
| Q1 2016 | $9,032,000 | +55.2% | 386,008 | +100.2% | 0.00% | +50.0% |
| Q4 2015 | $5,821,000 | -70.8% | 192,798 | -61.6% | 0.00% | -71.4% |
| Q3 2015 | $19,962,000 | +59.4% | 502,461 | +177.1% | 0.01% | +75.0% |
| Q2 2015 | $12,522,000 | +83.3% | 181,331 | +45.1% | 0.00% | +33.3% |
| Q1 2015 | $6,833,000 | -48.3% | 125,003 | -59.7% | 0.00% | -40.0% |
| Q4 2014 | $13,211,000 | +7.0% | 309,963 | -19.9% | 0.01% | 0.0% |
| Q3 2014 | $12,348,000 | -7.5% | 386,974 | -39.9% | 0.01% | 0.0% |
| Q2 2014 | $13,349,000 | +27.0% | 644,293 | +18.6% | 0.01% | +25.0% |
| Q1 2014 | $10,510,000 | +23.0% | 543,186 | +54.3% | 0.00% | 0.0% |
| Q4 2013 | $8,546,000 | +96.7% | 351,970 | +74.0% | 0.00% | +100.0% |
| Q3 2013 | $4,345,000 | – | 202,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |